Vimarsana
Biggest News Aggregation in the World

Interferon Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Interferon Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Interferon Type Today - Breaking & Trending Today

Investegate |Sareum Holdings PLC Announcements | Sareum Holdings PLC: Sareum Notes New UK Government Covid-19 Initiative - Vimarsana News

Investegate |Sareum Holdings PLC Announcements | Sareum Holdings PLC: Sareum Notes New UK Government Covid-19 Initiative

About the AGILE Clinical Trial Platform On 13 February 2021, the Department of Health and Social Care announced a new initiative under which the UK government is providing millions of pounds of additional funding to expand the new AGILE clinical trial platform. The funding has been awarded by the Medical Research Council (MRC) and co-funded though the National Institute for Health Research (NIHR). This new platform will allow for global innovators to progress cutting-edge treatments for COVID-19 through all 3 clinical trial phases in the UK, further protecting our supply ch...

TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy - Vimarsana News

TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy

Search jobs 14-Dec-2020 TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy Findings published in Nature support scientific rationale for Sareum’s SDC-1801 development programme in Covid-19 and its recent grant award from UKRI Cambridge, UK, 14 December 2020 – Sareum Holdings plc (AIM: SAR), the specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases, is pleased to note that a multi-cen...